Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

WeiDong Han

Showing results (331-340 of 371) with videos related to

Pageof 38
Sort By:
Blood|June 20, 2020
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphomaChuan Tong, Yajing Zhang, Yang Liu, et al.
Journal of Hematology & Oncology|May 20, 2020
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Signal Transduction and Targeted Therapy|March 18, 2026
DUSP6 ablation restores CAR T-cell fitness impaired by tumor CD58 loss through invigoration of AP-1 signalingXinran Ma, Yang Zhang, Yao Wang, et al.
Therapeutic Advances in Medical Oncology|April 7, 2023
A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignanciesDa Li, Hong Pan, Wei Wang, et al.
International Journal of Biological Sciences|March 14, 2022
Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axisYing Wang, Yunjing Zhang, Xinwan Su, et al.
Stem Cells (Dayton, Ohio)|August 16, 2019
Targeted Migration of Human Adipose-Derived Stem Cells to Secondary Lymphoid Organs Enhances Their Immunomodulatory Effect and Prolongs the Survival of Allografted Vascularized CompositesTian Ma, ShaoLiang Luan, Ran Tao, et al.
Frontiers in Oncology|February 17, 2022
Exploring the Interobserver Agreement in Computer-Aided Radiologic Tumor Measurement and Evaluation of Tumor ResponseHongsen Li, Jiaying Shen, Jiawei Shou, et al.
Science (New York, N.Y.)|April 18, 2020
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cellsZhiwei Zhou, Huabin He, Kun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2020
Camrelizumab Plus Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma: A Single-Arm, Open-Label, Phase II TrialQian Mei, Wenying Zhang, Yang Liu, et al.
Science China. Life Sciences|March 25, 2016
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cellsYajing Zhang, Wenying Zhang, Hanren Dai, et al.
Pageof 38

Showing results (331-340 of 371) with videos related to

Sort By:
Pageof 38
Blood|June 20, 2020
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphomaChuan Tong, Yajing Zhang, Yang Liu, et al.
Journal of Hematology & Oncology|May 20, 2020
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Signal Transduction and Targeted Therapy|March 18, 2026
DUSP6 ablation restores CAR T-cell fitness impaired by tumor CD58 loss through invigoration of AP-1 signalingXinran Ma, Yang Zhang, Yao Wang, et al.
Therapeutic Advances in Medical Oncology|April 7, 2023
A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignanciesDa Li, Hong Pan, Wei Wang, et al.
International Journal of Biological Sciences|March 14, 2022
Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axisYing Wang, Yunjing Zhang, Xinwan Su, et al.
Stem Cells (Dayton, Ohio)|August 16, 2019
Targeted Migration of Human Adipose-Derived Stem Cells to Secondary Lymphoid Organs Enhances Their Immunomodulatory Effect and Prolongs the Survival of Allografted Vascularized CompositesTian Ma, ShaoLiang Luan, Ran Tao, et al.
Frontiers in Oncology|February 17, 2022
Exploring the Interobserver Agreement in Computer-Aided Radiologic Tumor Measurement and Evaluation of Tumor ResponseHongsen Li, Jiaying Shen, Jiawei Shou, et al.
Science (New York, N.Y.)|April 18, 2020
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cellsZhiwei Zhou, Huabin He, Kun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2020
Camrelizumab Plus Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma: A Single-Arm, Open-Label, Phase II TrialQian Mei, Wenying Zhang, Yang Liu, et al.
Science China. Life Sciences|March 25, 2016
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cellsYajing Zhang, Wenying Zhang, Hanren Dai, et al.
Pageof 38